E-mail this story

More pressure to justify cost of cancer drugs versus benefits

(Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments.

By Deena Beasley

December 13, 2012

Send to (as many as 3 e-mail addresses, separated by commas):

Send me a copy.

From:

200 characters remaining